Drug intelligence / Profile preview

diethylnitrosamine

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral, Inhalation, Topical
01

Overview

Diethylnitrosamine (DEN), also known as N-nitrosodiethylamine, is a potent carcinogenic compound found in various environmental sources such as tobacco smoke, processed meats, cheese, soybean products, water supplies, cosmetics, and some pharmaceutical agents[1][4]. It is not used therapeutically but is widely employed in research to induce hepatocellular carcinoma (HCC) and other tumors in experimental animal models due to its strong hepatocarcinogenic and mutagenic properties[1][3][5]. DEN exerts its effects primarily through metabolic activation that generates high levels of reactive oxygen species (ROS), leading to DNA damage via alkylation and oxidative stress. This results in mutations that drive carcinogenesis[1][5][6]. The compound is especially notable for inducing liver cancer that closely mimics human HCC pathology; thus it serves as a standard agent for preclinical studies of liver cancer mechanisms and therapies[1].

Other names
diethylnitrosamineDENN-nitrosodiethylamine
02

Targets

DNA

Beyond the preview

Go deeper on diethylnitrosamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diethylnitrosamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call